US FDA okays Ketotop patch as OTC product

Pacific Pharma says its anti-inflammatory pain reliever Ketotop (ketoprofen transdermal patch) has been registered to the US Food and Drug Administration as an over-the-counter drug, heralding a new opportunity to export it to the US market.

Launched in 1994 with a big popularity, Ketotop patch was developed through a five-year intensive study under the technical assistance from the US-based...